Providence Cardiomyopathy Program
Our multidisciplinary Hypertrophic Cardiomyopathy (HCM) center will provide the most comprehensive and cutting edge care for patients and their families having either a diagnosis of, or concern for HCM. We have assembled at team of physicians and healthcare professionals from some of the world’s best institutions.
Our collective goal is to deliver individually tailored therapies for each of our patients. Since HCM is often a genetically mediated condition, we provide access to genetics testing to our patients and their families, if needed. Furthermore, we have access to the national community of HCM specialists and are able to direct family members who do not live locally to their closest reputable HCM center should they require further management.
We pride ourselves in ensuring that our patients will come away from a consultation empowered by their understanding of HCM. They will be reassured by the knowledge that there is a team of professionals highly trained in the management of their specific condition providing access to the most up to date, evidence based treatments available.
What is hypertrophic CM?
Hypertrophic Cardiomyopathy is a complex, predominantly genetically mediated heart disease, affecting approximately 1 in 500 individuals. The disease is characterized by excessive thickening of the heart muscle, most commonly in the septum, which is the muscular wall that separates the lower chambers of the heart. Read more.
What is amyloidosis?
Amyloidosis is a rare disease that occurs when an abnormal protein called amyloid deposits on organs in the body, including the heart, kidney, liver, gastrointestinal tract, and nervous system. Read more.